Predominance of high-risk human papillomavirus genotype 16 and 39 in women with premalignant and malignant cervical pathology from Raipur, Chhattisgarh: Clinical evaluation of tagging oligonucleotide cleavage and extension mediated genotyping assay
Conclusion: Anyplex HR-HPV assay is arguably the useful assay for better patient management and can be useful for HR-HPV screening by its unique individual genotype identification of all HR-HPV. Finding of HPV 16, 39, 18, 33 and coinfection of 16,18 and 16, 18, 33 in CIN and CC would help vaccine manufacturer to design specific future HPV polyvalent vaccine preparation to curb down the CC-associated mortality.
Source: Indian Journal of Medical Microbiology - Category: Microbiology Authors: Sanjay Singh Negi Anudita Bhargava Priyanka Singh Sarita Aggarwal Nighat Hussain Padma Das Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Cervical Cancer | Cervical Cancer Vaccine | Colposcopy | Cytology | Epidemiology | Genital Warts | Human Papillomavirus (HPV) | India Health | Microbiology | Pathology | Skin Cancer | Squamous Cell Carcinoma | Study | Vaccines | Women